PATTERN RECOGNITION RECEPTORS (PRRs), PAMPs & DAMPs
The innate immune system relies on specialised receptors to recognise danger rapidly and accurately. These receptors, known as pattern recognition receptors (PRRs), detect conserved molecular patterns on microbes or signals released from damaged cells. Unlike the adaptive immune system, which generates highly specific responses, the innate system uses these receptors to identify broad categories of threats within minutes. This early detection is essential for triggering inflammation, recruiting immune cells and activating downstream defences that ultimately shape the adaptive response.
What You Need to Know
Pattern recognition receptors (PRRs) are innate immune receptors that allow immune cells to rapidly detect danger. They do this by recognising two broad categories of molecular signals: pathogen-associated molecular patterns (PAMPs), conserved structural motifs found on microbes, and damage-associated molecular patterns (DAMPs), endogenous molecules released from host cells that are injured, stressed, or dying. PRRs are expressed on the cell surface, within endosomes, and in the cytoplasm, positioning them to detect extracellular pathogens, internalised microbes, and intracellular danger signals.
PAMPs include structures such as bacterial cell wall components, viral nucleic acids, and fungal carbohydrates, molecular features that are essential for microbial survival and therefore difficult for pathogens to alter. DAMPs, in contrast, originate from the host and include intracellular proteins, nucleic acids, and metabolites that are normally hidden from immune recognition but become exposed following cell damage or necrosis. Together, these signals allow the immune system to respond not only to infection but also to sterile injury.
Recognition of PAMPs and DAMPs through PRRs triggers a coordinated inflammatory response that includes:
Activation of intracellular signalling pathways, meaning cascades of proteins that transmit danger signals inside the cell
Production of cytokines and chemokines, soluble mediators that recruit and activate other immune cells
Induction of antimicrobial mechanisms that limit pathogen survival
PRR signalling links innate and adaptive immunity by shaping the local inflammatory environment and influencing how antigen-presenting cells activate lymphocytes. Through this process, early danger detection helps determine the magnitude, timing, and quality of downstream immune responses.
Beyond the Basics
Types of Pattern Recognition Receptors
Pattern recognition receptors are strategically located on the cell surface, within endosomes, and in the cytoplasm so that immune cells can detect pathogens regardless of where they are encountered. This distribution allows recognition of extracellular microbes, internalised pathogens, and intracellular infection. Different PRR families specialise in detecting distinct molecular patterns, ensuring broad coverage of bacterial, viral, and fungal threats.
Toll-like Receptors (TLRs)
Toll-like receptors are among the best-characterised PRRs and are expressed on the cell surface and within endosomal compartments. Their location determines what they detect. Surface TLRs primarily recognise bacterial and fungal components, while endosomal TLRs detect nucleic acids from viruses and intracellular bacteria. Once engaged, TLRs activate transcription factors such as NF-κB and interferon regulatory factors, leading to inflammatory cytokine production and antiviral responses.
Specific TLRs recognise distinct microbial components, for example:
TLR4 binds lipopolysaccharide (LPS), a structural component of Gram-negative bacterial cell walls
TLR3 detects double-stranded RNA, a replication intermediate produced by many viruses
Through these pathways, TLR activation initiates inflammation while simultaneously shaping antiviral immunity.
NOD-like Receptors (NLRs)
NOD-like receptors are cytoplasmic PRRs that detect bacterial products and signals associated with cellular stress or damage. Some NLRs assemble into inflammasomes, large multiprotein complexes that activate inflammatory caspases. This activation leads to the maturation and release of interleukin-1β and interleukin-18, cytokines that drive fever, leukocyte recruitment, and amplification of inflammation.
Inflammasome activation is particularly important when pathogens or danger signals are detected inside the cell, a context where surface receptors alone would be insufficient. Dysregulated inflammasome activity is implicated in chronic inflammatory and autoinflammatory diseases, linking innate sensing directly to pathology.
RIG-I–like Receptors (RLRs)
RIG-I–like receptors are cytoplasmic sensors specialised for viral detection. They recognise viral RNA produced during replication, allowing infected cells to detect viruses even before viral particles are released. Activation of RLRs triggers strong type I interferon responses, which establish an antiviral state in both the infected cell and surrounding tissues.
This early interferon signalling limits viral replication and spread while enhancing antigen presentation, positioning RLRs as key sensors in antiviral defence.
C-type Lectin Receptors (CLRs)
C-type lectin receptors are expressed primarily on dendritic cells and macrophages and specialise in recognising carbohydrate structures, particularly those found on fungal cell walls. These receptors bind sugars such as β-glucans and mannans, molecular patterns that are common in fungi but rare in host tissues.
CLR signalling contributes to phagocytosis, cytokine production, and shaping of adaptive immune responses, particularly those involved in antifungal immunity.
PAMPs: Recognising Microbial Signatures
Pathogen-associated molecular patterns are conserved molecular structures that are unique to microbes and essential for their survival, making them difficult for pathogens to alter. Because these structures are shared across broad classes of microorganisms, a limited set of PRRs can detect a wide range of infections.
Common PAMPs include:
Peptidoglycan and lipoteichoic acid from Gram-positive bacteria
Lipopolysaccharide from Gram-negative bacteria
Viral RNA or DNA produced during replication
Fungal β-glucans present in cell walls
Recognition of PAMPs allows the immune system to respond immediately to infection without prior exposure or immunological memory.
DAMPs: Signals of Tissue Damage and Stress
Damage-associated molecular patterns originate from host cells undergoing injury, stress, or necrosis. These molecules are normally confined within cells but become immunologically visible when tissue integrity is disrupted. Their detection signals danger even in the absence of infection.
Examples of DAMPs include:
Extracellular ATP released from dying cells
HMGB1, a nuclear protein released during cell damage
Uric acid crystals generated during cell breakdown
Heat-shock proteins expressed during cellular stress
DAMPs activate many of the same PRRs as PAMPs, allowing inflammation to occur in sterile settings such as trauma, ischemia, or tissue necrosis.
Inflammatory Signalling Pathways
Binding of PAMPs or DAMPs to PRRs initiates intracellular signalling cascades, sequences of protein interactions that transmit danger signals from the receptor to the nucleus. These cascades result in the coordinated production of inflammatory mediators and antimicrobial responses.
Key outcomes of PRR signalling include:
Production of cytokines such as interleukin-1, interleukin-6, and tumour necrosis factor-α
Recruitment of neutrophils and monocytes to sites of infection or injury
Enhancement of antigen processing and presentation
Activation of type I interferons during viral infection
Together, these responses create an inflammatory environment that contains threats and prepares the immune system for sustained defence.
Clinical Connections
PRR signalling plays a central role in determining whether inflammation is protective or harmful. While appropriate PRR activation is essential for pathogen clearance, excessive or sustained activation can drive significant tissue damage. A well-recognised example is TLR4 activation by endotoxin, specifically lipopolysaccharide from Gram-negative bacteria, which can trigger overwhelming cytokine release. In sepsis, this uncontrolled inflammatory response contributes to widespread vasodilation, capillary leak, and organ dysfunction rather than effective pathogen control.
Several clinical conditions are directly linked to altered PRR signalling and its downstream effects:
Septic shock associated with excessive TLR activation and cytokine release
Increased infection susceptibility due to impaired PRR or adaptor protein function
Autoinflammatory disorders driven by dysregulated inflammasome and NOD-like receptor activity
Autoinflammatory diseases, including periodic fever syndromes, commonly involve abnormal activation of inflammasomes, leading to excessive production of interleukin-1β and interleukin-18. These cytokines drive recurrent systemic inflammation in the absence of infection or autoantibodies. Because these conditions arise from innate immune dysregulation rather than adaptive immune dysfunction, they illustrate the clinical consequences of PRR signalling that is active but poorly controlled.
PRRs and their signalling pathways are also emerging therapeutic targets. Modulating PRR activation is being explored in inflammatory bowel disease and autoimmune conditions, where dampening innate immune signalling may reduce chronic inflammation. In oncology and vaccinology, the same pathways are being harnessed in a controlled manner, using PRR agonists to enhance immune activation and improve antigen presentation. Understanding PRR biology therefore supports clinical reasoning across infection, inflammation, immune deficiency, and immune-targeted therapies.
Concept Check
What are the differences between PAMPs and DAMPs?
How do TLRs and NLRs differ in their location and the danger signals they detect?
What cytokines are commonly produced in response to PRR activation?
Why are PAMPs reliable indicators of infection?
How do PRRs help shape adaptive immune responses?